Hospitals and medical facilities are currently integrating medical staff management, administrative and repetitive documentation routines, and department-wide simple access to patient administrative and clinical data. Additionally, data sharing across multimodal hospitals and their branch offices is necessary, which is driving up the need for interoperable, high-quality solutions. The need for clinical workflow systems has been significantly increased by carers' demands for patient-centered care delivery and increased clinician productivity.Many organisations in the public and private sectors have acknowledged the importance of clinical workflow management systems. Furthermore, clinical centres are launching programmes to encourage the installation and integration of clinical decision support systems and electronic health records (EHRs). This is thus expected to encourage hospitals to use these services, which will have a beneficial effect on the market for clinical workflow solutions.
Clinical workflow solutions are becoming more and more popular among healthcare companies looking for more appealing, seamless, and effective ways to enhance patient outcomes and safety. This is because these solutions make it possible for real-time health data to flow continuously, leading to more informed decisions and outcomes regarding patient care. Clinical workflow solutions are expected to become more popular in the next years because they have qualities that can improve treatment quality, coordination of care, and patient satisfaction while also reducing the likelihood of medication errors and adverse drug events.
One major barrier to the adoption of IT systems in hospitals is the lack of competent staff. The increasing number of healthcare IT efforts is making it difficult for suppliers and organisations in the healthcare industry to locate qualified employees. Both in industrialised regions like the United States and Europe as well as in developing ones, there is now a marked shortage of healthcare IT personnel. Therefore, a major obstacle to the market's expansion is the shortage of qualified professionals.
Clinical Workflow Solutions Market based on Product
• Data Integration
• Real-time Communication Solutions
• Workflow Automation Solutions
• Care Collaboration Solutions
• Enterprise Reporting & Analytics Solutions
Clinical Workflow Solutions Market based on End user
• Hospitals
• Long-term care facilities
• Ambulatory care Centers
Clinical Workflow Solutions Market based on Geography
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
In 2022, the revenue share of the data integration solutions segment was above 26.4%. The necessity for integration to contain rising costs and growing data quantities has made data integration systems the top choice among healthcare service providers. Integrated systems that let clients view the patient's information while receiving care are being aggressively adopted by hospitals and other carers. This fueled the data integration systems market's expansion in 2019. The segment has grown as a result of factors like interoperability solutions, regulatory reforms and mandates, increased use of electronic medical records, and a shift in emphasis towards value-based services.
The market for care collaboration solutions has grown significantly in the last several years, and demand is predicted to rise during the projected period. The reason for this is the heightened focus on patient-centered services. Growing patient populations worldwide also push industry participants to create more practical and efficient solutions. Care management solutions enhance patient care while saving time and money by offering efficient workflow techniques.
Hospitals held the largest market value share of clinical workflow solutions in 2022o46%odue to the growth in healthcare facilities and the related data that needs to be managed effectively and privately. Furthermore, the market expansion of the category is expected to be bolstered by supporting initiatives implemented by the governments of different countries to improve and streamline the data handling capacity in the healthcare sectors. For instance, more than 60% of hospitals have implemented EHR technology, according to data released by the Healthcare Information and Management Systems Society (HIMSS) in 2019. Moreover, the West Health Institute (WHI) stated that increased usage of interoperability technologies may lead to a significant decrease in US healthcare spending.
Additionally, it is projected that the market would rise during the analysis period due to the persistent trend towards linked hospitals and efficient management solutions. One of the main reasons for the segment's strong revenue share is the growing demand for unified important clinical communications, integrated and collaborative care delivery, and a simplified call scheduling process.
Conversely, it is anticipated that ambulatory care centres will experience the greatest expansion during the course of the analysis. The primary cause of this is an increase in out-patient hospital admissions. IT-based solution integration significantly lowers medical errors and improves communication between chemists, doctors, nurses, and patients' families in ambulatory care facilities.
North America held a 40.7% market share in 2022 as a result of a rise in hospital patient admissions and research and development efforts related to healthcare solutions, both of which increase the amount of data produced and are anticipated to drive market expansion. Additionally, more money being spent on healthcare digitalization to safeguard information sharing inside organisations is a major factor in the expansion of clinical workflow solutions in the area.
The prominent players in the global clinical workflow solutions market Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), Koninklijke Philips N.V. (Netherlands), Cerner Corporation (US), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), GE Healthcare (US), Epic Systems Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Spok, Inc. (US), Vocera Communications, Inc. (US), Capsule Technologies, Inc. (US), AMETEK, Inc. (US), NextGen Healthcare (US), Azure Healthcare Limited (Australia), Getinge Group (Sweden), Change Healthcare (US), athenahealth (US), Sonitor Technologies, Inc. (Norway), and Connexall (Canada).
• This report illustrates the most vital attributes of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Clinical Workflow Solutions Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
Table of Contents 1. Executive Summary 2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Product: Market Size & Analysis 5.1. Overview 5.2. Data Integration 5.3. Real-time Communication Solutions 5.4. Workflow Automation Solutions 5.5. Care Collaboration Solutions 5.6. Enterprise Reporting & Analytics Solutions 5.7. Other Applications 6. End User: Market Size & Analysis 6.1. Overview 6.2. Hospitals 6.3. Long-term care facilities 6.4. Ambulatory care Centers 7. Geography: Market Size & Analysis 7.1. Overview 7.2. North America (U.S., Mexico, Canada) 7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 7.5. Latin America (Brazil, Argentina) 7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 8. Competitive Landscape 8.1. Competitor Comparison Analysis 8.2. Market Developments 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 8.2.2. Product Launches and execution 9. Vendor Profiles 9.1. Cerner Corporation 9.1.1. Overview 9.1.2. Financial Overview 9.1.3. Product Offerings 9.1.4. Developments 9.1.5. Business Strategy 9.2. Allscripts Healthcare Solutions, Inc. 9.2.1. Overview 9.2.2. Financial Overview 9.2.3. Product Offerings 9.2.4. Developments 9.2.5. Business Strategy 9.3. NXGN Management, LLC 9.3.1. Overview 9.3.2. Financial Overview 9.3.3. Product Offerings 9.3.4. Developments 9.3.5. Business Strategy 9.4. Koninklijke Philips N.V. 9.4.1. Overview 9.4.2. Financial Overview 9.4.3. Product Offerings 9.4.4. Developments 9.4.5. Business Strategy 9.5. McKesson Corporation 9.5.1. Overview 9.5.2. Financial Overview 9.5.3. Product Offerings 9.5.4. Developments 9.5.5. Business Strategy 9.6. Hill-Rom Services Inc. 9.6.1. Overview 9.6.2. Financial Overview 9.6.3. Product Offerings 9.6.4. Developments 9.6.5. Business Strategy 9.7. General Electric 9.7.1. Overview 9.7.2. Financial Overview 9.7.3. Product Offerings 9.7.4. Developments 9.7.5. Business Strategy 9.8. Cisco 9.8.1. Overview 9.8.2. Financial Overview 9.8.3. Product Offerings 9.8.4. Developments 9.8.5. Business Strategy 9.9. Stanly Healthcare 9.9.1. Overview 9.9.2. Financial Overview 9.9.3. Product Offerings 9.9.4. Developments 9.9.5. Business Strategy 9.10. ASCOM 9.10.1. Overview 9.10.2. Financial Overview 9.10.3. Product Offerings 9.10.4. Developments 9.10.5. Business Strategy 10. Analyst Opinion 11. Annexure 11.1. Report Scope 11.2. Market Definitions 11.3. Research Methodology 11.3.1. Data Collation and In-house Estimation 11.3.2. Market Triangulation 11.3.3. Forecasting 11.4. Report Assumptions 11.5. Declarations 11.6. Stakeholders 11.7. Abbreviations
Tables TABLE 1. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 2. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR DATA INTEGRATION, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR REAL-TIME COMMUNICATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR WORKFLOW AUTOMATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR CARE COLLABORATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 6. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR ENTERPRISE REPORTING & ANALYTICS SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 7. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 8. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR HOSPITALS, 2021-2030 (USD BILLION) TABLE 9. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR LONG-TERM CARE FACILITIES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 10. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR AMBULATORY CARE CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 11. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 12. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 13. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 14. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 15. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 16. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 17. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 18. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 19. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 20. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 21. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 22. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 23. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 24. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 25. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 26. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 27. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 28. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 29. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 30. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 31. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 32. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 33. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 34. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 35. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 36. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 37. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 38. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 39. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 40. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 41. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 42. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 43. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 44. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 45. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 46. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 47. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 48. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 49. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 50. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 51. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 52. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION) TABLE 53. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 54. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 55. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 56. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 57. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 58. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 59. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION) TABLE 60. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 61. CERNER CORPORATION: FINANCIALS TABLE 62. CERNER CORPORATION: PRODUCTS & SERVICES TABLE 63. CERNER CORPORATION: RECENT DEVELOPMENTS TABLE 64. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: FINANCIALS TABLE 65. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCTS & SERVICES TABLE 66. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: RECENT DEVELOPMENTS TABLE 67. NXGN MANAGEMENT, LLC: FINANCIALS TABLE 68. NXGN MANAGEMENT, LLC: PRODUCTS & SERVICES TABLE 69. NXGN MANAGEMENT, LLC: RECENT DEVELOPMENTS TABLE 70. KONINKLIJKE PHILIPS N.V.: FINANCIALS TABLE 71. KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES TABLE 72. KONINKLIJKE PHILIPS N.V.: RECENT DEVELOPMENTS TABLE 73. MCKESSON CORPORATION: FINANCIALS TABLE 74. MCKESSON CORPORATION: PRODUCTS & SERVICES TABLE 75. MCKESSON CORPORATION: RECENT DEVELOPMENTS TABLE 76. HILL-ROM SERVICES INC.: FINANCIALS TABLE 77. HILL-ROM SERVICES INC.: PRODUCTS & SERVICES TABLE 78. HILL-ROM SERVICES INC.: RECENT DEVELOPMENTS TABLE 79. GENERAL ELECTRIC: FINANCIALS TABLE 80. GENERAL ELECTRIC: PRODUCTS & SERVICES TABLE 81. GENERAL ELECTRIC: DEVELOPMENTS TABLE 82. CISCO: FINANCIALS TABLE 83. CISCO: PRODUCTS & SERVICES TABLE 84. CISCO: RECENT DEVELOPMENTS TABLE 85. STANLY HEALTHCARE: FINANCIALS TABLE 86. STANLY HEALTHCARE: PRODUCTS & SERVICES TABLE 87. STANLY HEALTHCARE: RECENT DEVELOPMENTS TABLE 88. ASCOM: FINANCIALS TABLE 89. ASCOM: PRODUCTS & SERVICES TABLE 90. ASCOM: RECENT DEVELOPMENTS
Publisher: IHR Insights
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support